If you’ve been diagnosed with TED and are seeking potential new treatment options, you might be interested in the LIDS clinical trial. The goal of this study is to investigate the effectiveness and safety of an oral
study drug called Linsitinib, in adults with active, moderate-to-severe TED. You may be eligible if you:
*Are over 18 years old
*Have TED symptoms that started within the past year
*Have been diagnosed with Graves’ and/or Hashimoto’s disease
If you’re interested in learning more, take this short prescreener questionnaire, and a member of the study team will reach out to qualified individuals with more information.